This study provides convincing evidence that JHP may partially ameliorate early NONFH by restoring the balance of lipid metabolism disorder and reversing pathological events during early NONFH progression by regulating the NAMPT/STK11/HMGCR/ACAT1 axis. This evidence concerns the gene HMGCR and Disorder of lipid metabolism.